3 New Strong Buy Ratings from Top-Rated Analysts: 11/14/2025
Here’s a peek at the latest picks from our Strong Buy Stocks from Top Wall Street Analysts screener:
- Infusystem Holdings (INFU) just got an upgrade following strong earnings
- MKS (MKSI) just crushed earnings — again
- Analysts project “line go up” action for Nerdwallet Inc (NRDS)
P.S. Get more alerts like this daily … Try WallStreetZen Premium.
A note from our sponsors...
Here's the Best Day to Buy Stocks Did you know the S&P 500 has a 100% history of soaring, beginning on one particular day every fall? We call this the "Green Day phenomenon." It works on 5,000 stocks. For example, Nvidia has a 100% history of soaring beginning on one particular day every single year. Click here to see the green days for 7 major stocks today.1. Infusystem Holdings (NYSEMKT: INFU)
InfuSystem provides infusion pump management services and other healthcare services, primarily serving oncology patients and their care providers. The company's Q3 2025 results met revenue expectations while beating on earnings, with management focused on margin expansion through operational efficiency improvements in its core Oncology business.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $10.45 — get current quote
Max 1-year forecast: $15.00
Why we're watching:
- Analyst support: INFU only has 2 ratings from analysts we cover, but they are both Strong Buys, reflecting confidence in the company's potential heading into 2026. See the ratings
- For a closer look — Roth Capital analyst Kyle Bauser (a top 22% rated analyst) recently reiterated his Strong Buy rating with a $14 price target following Q3 earnings, noting that while revenue estimates were reduced slightly, adjusted EBITDA and EPS estimates increased due to profitability improvements and share buybacks reducing the share count.
- The price action is right — shares have surged 21.51% over the past three months.
- Industry ranking context: INFU is currently the 3rd highest-rated stock in the Medical industry, which has an Industry Rating of B out of 45 companies tracked.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — INFU demonstrates exceptional momentum characteristics with Safety (A grade, top 100% percentile) and Momentum (A grade, top 100% percentile). See all 7 Zen Component Grades here
2. MKS (NASDAQ: MKSI)
MKS provides instruments, systems, and process control solutions for semiconductor manufacturing and other advanced industries worldwide. After delivering Q3 results that beat earnings expectations and raising guidance, the stock has surged to fresh highs, demonstrating strong momentum as the semiconductor equipment cycle recovers.
Zen Rating: B (Buy) — see full analysis
Recent Price: $157.00 — get current quote
Max 1-year forecast: $180.00
Why we're watching:
- Analyst support: MKSI receives solid overall backing from the analysts we track with 4 Strong Buy ratings, 2 Buy ratings, 1 Hold rating, and 1 Strong Sell rating. See the ratings
- Looking at the more bullish takes, Benchmark's Mark Miller (a top 2% rated analyst) and KeyBanc's Steve Barger (a top 5% rated analyst) both maintain Strong Buy ratings with $180 price targets, representing 17.93% upside potential from current levels.
- Industry ranking context: MKSI is currently the #1 highest-rated stock in the Scientific & Technical Instrument industry, which has an Industry Rating of B out of 24 companies tracked.
- Zen Rating highlights: Buy (B) stocks average +19.88% per year — MKSI has market-beating potential.
- Component Grades: The company demonstrates outstanding performance across Value, Safety, Sentiment, and AI (B grades), positioning it as a rare combination of value and growth. See all 7 Zen Component Grades here
3. Nerdwallet Inc (NASDAQ: NRDS)
NerdWallet operates a personal finance platform providing educational content, comparison tools, and product marketplaces to help consumers make informed financial decisions. The company's Q3 2025 results surpassed estimates, and with shares up 53% over three months, momentum is building as the company benefits from strong execution and improving market conditions.
Zen Rating: A (Strong Buy) — see full analysis
Recent Price: $14.50 — get current quote
Max 1-year forecast: $19.00
Why we're watching:
- Analyst support: NRDS commands a Strong Buy consensus among the analysts we track, indicating Smart Money’s seal of approval. See the ratings
- For example, Truist Securities' Youssef Squali (a top 2% rated analyst) maintains a Strong Buy rating with a $19 price target, representing 31.03% upside potential and the highest target among covering analysts.
- Barclays researcher Ross Sandler (a top 9% rated analyst) and KeyBanc's Justin Patterson (a top 8% rated analyst) both maintain Strong Buy ratings with targets of $17 and $16 respectively, citing the company's margin expansion opportunities and strategic positioning.
- Industry ranking context: NRDS is currently the 4th highest-rated stock in the Internet Content & Information industry, which has an Industry Rating of B out of 54 companies tracked.
- Zen Rating highlights: Strong Buy (A) stocks average +32.52%/yr — NRDS ranks in the top 5% of all stocks tracked with particularly impressive Financials (A grade).
- The company also demonstrates balanced strength with Momentum (B grade) and Value (B grade) complementing its excellent financial health metrics. See all 7 Zen Component Grades here
What to Do Next?
Want to get in touch? Email us at news@wallstreetzen.com.
Keep Reading
See All News
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.